Xtant Medical Holdings, Inc. (FRA:XMS)
Germany · Delayed Price · Currency is EUR 0.5350
+0.0050 (0.94%)
At close: Nov 28, 2025
Xtant Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 133.08 | 117.27 | 91.3 | 57.97 | 55.15 | 53.19 | Upgrade |
Other Revenue | - | - | - | - | 0.12 | 0.15 | Upgrade |
| 133.08 | 117.27 | 91.3 | 57.97 | 55.26 | 53.34 | Upgrade | |
Revenue Growth (YoY) | 16.88% | 28.44% | 57.50% | 4.90% | 3.61% | -17.54% | Upgrade |
Cost of Revenue | 50.54 | 49.05 | 35.84 | 25.83 | 22.77 | 18.95 | Upgrade |
Gross Profit | 82.54 | 68.22 | 55.47 | 32.14 | 32.49 | 34.39 | Upgrade |
Selling, General & Admin | 74.03 | 77.91 | 64.29 | 37.98 | 34.87 | 34.49 | Upgrade |
Research & Development | 2.17 | 2.39 | 1.34 | 0.92 | 0.87 | 0.66 | Upgrade |
Operating Expenses | 76.2 | 80.29 | 65.63 | 38.89 | 35.74 | 35.14 | Upgrade |
Operating Income | 6.35 | -12.07 | -10.16 | -6.76 | -3.25 | -0.75 | Upgrade |
Interest Expense | -4.09 | -4.16 | -2.94 | -1.69 | -1 | -5.98 | Upgrade |
Interest & Investment Income | - | - | 0.15 | 0.03 | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.05 | 0.01 | 0.27 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -0.05 | -0.03 | -0.05 | - | - | - | Upgrade |
EBT Excluding Unusual Items | 2.26 | -16.26 | -12.73 | -8.42 | -4.25 | -6.73 | Upgrade |
Legal Settlements | - | - | - | - | -0.6 | - | Upgrade |
Other Unusual Items | - | - | 11.69 | - | - | - | Upgrade |
Pretax Income | 2.26 | -16.26 | -1.04 | -8.42 | -4.85 | -6.73 | Upgrade |
Income Tax Expense | 0.51 | 0.19 | -1.7 | 0.07 | - | 0.3 | Upgrade |
Net Income | 1.75 | -16.45 | 0.66 | -8.49 | -4.85 | -7.02 | Upgrade |
Net Income to Common | 1.75 | -16.45 | 0.66 | -8.49 | -4.85 | -7.02 | Upgrade |
Shares Outstanding (Basic) | 139 | 134 | 119 | 94 | 85 | 28 | Upgrade |
Shares Outstanding (Diluted) | 147 | 134 | 127 | 94 | 85 | 28 | Upgrade |
Shares Change (YoY) | 11.96% | 5.42% | 34.76% | 10.10% | 199.85% | 116.50% | Upgrade |
EPS (Basic) | 0.01 | -0.12 | 0.01 | -0.09 | -0.06 | -0.25 | Upgrade |
EPS (Diluted) | 0.01 | -0.12 | 0.01 | -0.09 | -0.06 | -0.25 | Upgrade |
Free Cash Flow | 5.17 | -16.01 | -10.97 | -7.11 | -1.68 | -2.28 | Upgrade |
Free Cash Flow Per Share | 0.04 | -0.12 | -0.09 | -0.08 | -0.02 | -0.08 | Upgrade |
Gross Margin | 62.02% | 58.17% | 60.75% | 55.44% | 58.79% | 64.48% | Upgrade |
Operating Margin | 4.77% | -10.30% | -11.13% | -11.65% | -5.89% | -1.41% | Upgrade |
Profit Margin | 1.32% | -14.03% | 0.72% | -14.64% | -8.77% | -13.17% | Upgrade |
Free Cash Flow Margin | 3.89% | -13.65% | -12.02% | -12.26% | -3.03% | -4.27% | Upgrade |
EBITDA | 10.9 | -7.85 | -6.98 | -5.46 | -1.92 | 1.33 | Upgrade |
EBITDA Margin | 8.19% | -6.69% | -7.65% | -9.42% | -3.48% | 2.49% | Upgrade |
D&A For EBITDA | 4.55 | 4.22 | 3.17 | 1.29 | 1.33 | 2.08 | Upgrade |
EBIT | 6.35 | -12.07 | -10.16 | -6.76 | -3.25 | -0.75 | Upgrade |
EBIT Margin | 4.77% | -10.30% | -11.13% | -11.65% | -5.89% | -1.41% | Upgrade |
Revenue as Reported | 133.08 | 117.27 | 91.3 | - | 55.26 | 53.34 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.